hotspot -WSS

hotspot

author：focus 2025-10-01 11:00:23 - browse：18226

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Millions may soon lose Medicaid when they don't have to

WSS

The thinking behind the controversial eating disorder chatbot Tessa

Timeline: Key moments in fight for gay rights

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Biden administration plans revamp of organ transplant system

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

How one medical school became remarkably diverse

Winning ticket for $1 billion Powerball jackpot sold in California

How to save PrEP access — and even expand it

Novo pauses ads for weight loss drug Wegovy amid demand

Psychedelics group wrestles with new pharma identity

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Activists slam private health insurers over coverage restrictions

Mom launches Girl Scout troop for LGBTQ youth in Texas

BioMarin wins approval for gene therapy to treat hemophilia A

Xenotransplantation trials will require adjusting expectations, experts say

hotspot

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Affordable Connectivity Program vital to health care, experts say

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Texas Department of Public Safety speaks out on migrant abuse allegations

Vir antibody drug aimed at influenza A fails in clinical trial

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

knowledge

entertainment

focus

focus